Polymorphisms in some proinflammatory genes (TNFα and β, IL-1β, IL-6, ADAM17) in severe chronic venous disease
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
36420762
DOI
10.1111/jdv.18770
Knihovny.cz E-zdroje
- MeSH
- chronická nemoc MeSH
- frekvence genu MeSH
- genetická predispozice k nemoci MeSH
- genotyp MeSH
- interleukin-1beta genetika MeSH
- interleukin-6 genetika MeSH
- jednonukleotidový polymorfismus MeSH
- kardiovaskulární nemoci * genetika MeSH
- lidé MeSH
- lymfotoxin-alfa genetika MeSH
- protein ADAM17 genetika MeSH
- TNF-alfa * genetika MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- ADAM17 protein, human MeSH Prohlížeč
- interleukin-1beta MeSH
- interleukin-6 MeSH
- lymfotoxin-alfa MeSH
- protein ADAM17 MeSH
- TNF-alfa * MeSH
BACKGROUND: Chronic venous disease (CVD) is a common disorder of lower extremities. OBJECTIVES: The study was scheduled to investigate the relationship between polymorphisms in major proinflammatory genes TNF α (-238 A/G; -308 A/G), TNF β (NcoI), IL-1β (+3953 T/C); IL-6 (-174 G/C; -596 G/C) and ADAM17 (3'TACE) and CVD risk. Genotype-phenotype study was calculated to test possible association between examined genotypes and phenotypes of CVD. METHODS: Finally, 150 CVD patients and 227 control subjects were enrolled to the study. Genotypes in proinflammatory gene polymorphisms were identified from isolated DNA by PCR method and restriction analysis. RESULTS: Significant differences in genotype distribution/allelic frequencies in TNF β gene, IL-1 β gene and in ADAM17 gene polymorphisms were found between CVD women and control ones. In the genotype-phenotype study, identified genotypes were associated with arterial hypertension (ADAM17, IL-6-men), ischaemic heart disease (TNF α and β genes), diabetes mellitus (ADAM17-women, TNF β-men), age of CVD onset (TNF α and IL-6), ulceration (ADAM17), duration of ulceration (ADAM17), ulceration recurrence (ADAM17-women), home care necessity (TNF α), varices surgery (TNF α), erysipelas development (ADAM17-men) and tumour development (TNF α). CONCLUSION: Studying of these polymorphisms associations can help us better identify patients at higher risk of developing severe CVD.
Zobrazit více v PubMed
Raffetto JD, Khalil RA. Mechanisms of lower extremity vein dysfunction in chronic venous disease and implications in management of varicose veins. Vessel Plus. 2021;5:36.
Raffetto JD, Ligi D, Maniscalco R, Khalil RA, Mannello F. Why venous leg ulcers have difficulty healing: overview on pathophysiology, clinical consequences, and treatment. J Clin Med. 2020;10:29.
Stana J, Maver U, Potočnik U. Genetic biases related to chronic venous ulceration. J Wound Care. 2019;28:59-65.
Bharath V, Kahn SR, Lazo-Langner A. Genetic polymorphisms of vein wall remodeling in chronic venous disease: a narrative and systematic review. Blood. 2014;124:1242-50.
Youn YJ, Lee J. Chronic venous insufficiency and varicose veins of the lower extremities. Korean J Intern Med. 2019;34:269-83.
Signorelli SS, Malaponte MG, Di Pino L, Costa MP, Pennisi G, Mazzarino MC. Venous stasis causes release of interleukin 1beta (IL-1beta), interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFalpha) by monocyte-macrophage. Clin Hemorheol Microcirc. 2000;22:311-6.
Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130:333-46.
Santler B, Goerge T. Chronic venous insufficiency - a review of pathophysiology, diagnosis, and treatment. J Dtsch Dermatol Ges. 2017;15:538-56.
Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in chronic wounds. Int J Mol Sci. 2016;17:2085.
Raffetto JD. Pathophysiology of chronic venous disease and venous ulcers. Surg Clin North Am. 2018;98:337-47.
Comerota A, Lurie F. Pathogenesis of venous ulcer. Semin Vasc Surg. 2015;28:6-14.
Kitchens BP, Snyder RJ, Cuffy CA. A literature review of pharmacological agents to improve venous leg ulcer healing. Wounds. 2020;32:195-207.
Tan MKH, Luo R, Onida S, Maccatrozzo S, Davies AH. Venous leg ulcer clinical practice guidelines: what is AGREEd? Eur J Vasc Endovasc Surg. 2019;57:121-9.
Nelson EA, Adderley U. Venous leg ulcers. BMJ Clin Evid. 2016;2016:1902-37.
Bonkemeyer Millan S, Gan R, Townsend PE. Venous ulcers: diagnosis and treatment. Am Fam Physician. 2019;100:298-305.
Kawaguchi M, Suzuki T. Gene expression and in situ localization of ADAM17 during skin wound healing. Int J Dermatol. 2014;53:e229-31.
Wallace HJ, Stacey MC. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers-correlations to healing status. J Invest Dermatol. 1998;110:292-6.
Wallace HJ, Vandongen YK, Stacey MC. Tumor necrosis factor-alpha gene polymorphism associated with increased susceptibility to venous leg ulceration. J Invest Dermatol. 2006;126:921-5.
Yu Y, Cao Y, Bell B, Chen X, Weiss RM, Felder RB, et al. Brain TACE (Tumor Necrosis Factor-α-Converting Enzyme) contributes to sympathetic excitation in heart failure rats. Hypertension. 2019;74:63-72.
Hajeer AH, Hutchinson IV. Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol. 2001;62:1191-9.
Pruessmeyer J, Ludwig A. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin Cell Dev Biol. 2009;20:164-74.
Slonková V, Slonková V Jr, Vašků A, Vašků V. Genetic predisposition for chronic venous insufficiency in several genes for matrix metalloproteinases (MMP-2, MMP-9, MMP-12) and their inhibitor TIMP-2. J Eur Acad Dermatol Venereol. 2017;31:1746-52.
Spinarová L, Spinar J, Vasků A, Pávková-Goldbergová M, Ludka O, Tomandl J, et al. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients. Exp Mol Pathol. 2008;84:251-5.
Tan JH, Price P, Gut I, Stacey MC, Warrington NM, Wallace HJ. Characterization of tumor necrosis factor-α block haplotypes associated with susceptibility to chronic venous leg ulcers in Caucasian patients. Hum Immunol. 2010;71:1214-9.
Orr L, Klement KA, McCrossin L, O'Sullivan Drombolis D, Houghton PE, Spaulding S, et al. A systematic review and meta-analysis of exercise intervention for the treatment of calf muscle pump impairment in individuals with chronic venous insufficiency. Ostomy Wound Manage. 2017;63:30-43.
Bolton L. Exercise and chronic wound healing. Wounds. 2019;31:65-7.
Ramelet AA. Venous ulcer healing: considerations for an optimal protocol. Ann Dermatol Venereol. 2021;148:209-10.
Fukaya E, Flores AM, Lindholm D, Gustafsson S, Zanetti D, Ingelsson E, et al. Clinical and genetic determinants of varicose veins. Circulation. 2018;138:2869-80.
Krysa J, Jones GT, van Rij AM. Evidence for a genetic role in varicose veins and chronic venous insufficiency. Phlebology. 2012;27:329-35.
Grant Y, Onida S, Davies A. Genetics in chronic venous disease. Phlebology. 2017;32:3-5.